<DOC>
	<DOCNO>NCT02988778</DOCNO>
	<brief_summary>This study evaluate non inferiority Eurofarma budesonide nasal spray x referral Astrazeneca budesonide . Half patient receive Eurofarma medication half patient receive Astrazeneca medication . There placebo group .</brief_summary>
	<brief_title>Clinical Study , Non Inferiority Between Noex® 50µg Versus Busonid® 50µg Treatment Allergic Rhinitis</brief_title>
	<detailed_description>Budesonide medicine already use register 20 year . Eurofarma intention collect data safety efficacy present local authority . This study draw treat patient persistent rhinitis moderate severe site locate locally Brazil .</detailed_description>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis , Allergic , Perennial</mesh_term>
	<criteria>1 . Age ≥ 12 2 . History allergic persistent rhinitis moderate severe least 2 year 3 . Proved allergic use PRICK RAST test 4 . Nasal symptom ( NIS ) &gt; 3 nasal obstruction &gt; 1 5 . Indication nasal corticosteroid use 6 . Washout nasal corticosteroid 14 day 7 . ICF 1 . Other type rhinitis 2 . Asthma non control 3 . Use oral/injectable corticoid 30 day screen 4. patient eligible complete diary 5. patient allergy substance medicine 6. non control disease</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>